Gemina Laboratories Ltd. announced a non-brokered private placement of 3,472,994 common shares at a price of CAD 0.75 per common share for gross proceeds of CAD 2,604,745.5 on March 27, 2023. The transaction included participation from related parties for 330,300 common shares. The company paid finder's fees of CAD 95,413.50 in the offering.

The securities are being subject to four months and one day hold period.